Welcome to RNA Therapeutics of the Future

The past 18 months have marked major breakthroughs for the field of RNA therapeutics, opening the floodgates to a wealth of investment and collaboration opportunities but - more importantly - to address unmet clinical needs.

The inaugural Next Generation RNA Therapeutics Summit is the first and only industry-dedicated forum focused on novel RNA therapeutics and vaccines that are shaping the future of this exciting field.

Here's What You Missed at the 2022 Summit:

Next generation RNA therapeutics and vaccines offer superior targeted delivery, selectivity, durability and scalability compared to the current generations.

Bringing together leading experts from large pharma, innovative biotech and KOLs of academics, this Summit will delve deep into innovations to advance novel classes of RNA therapeutics and vaccines for better protein expression, simplified production, and superior efficacy compared to conventional approaches, with the aim of accelerating the field towards successful proof of concept and robust therapeutic development.

Join 80+ Directors, Heads and VPs of RNA Therapeutics, Chemistry, Delivery and New Therapeutics to understand how the future landscape is shaping, how companies are strategizing to leverage and address key challenges.

Capture

Explore the Current State of Play & Future of Next Generation RNA Therapeutics
With the recent success of RNA therapeutics & the rise of novel technologies & modalities, hear from companies like Pfizer, BioNTech and Tevard Bioscience on the current state of play of the RNA field and how next-generation RNA therapeutics & vaccines are shaping the future RNA landscape

icon2

Discover Next Generation RNA Therapeutics & Vaccine Modalities
As the industry continues to advance in next-generation RNA therapeutics, it is becoming more important than ever to determine high-value candidates for target specificity and efficacy. Hear expert insights into the hottest modalities from Orna Therapeutics, Replicate Bioscience & Ziphius Vaccines

3

Optimize the Latest Advancements of Next Generation RNA Formulation & Delivery Strategies
Delve into pioneering ways to advance delivery systems, LNP & polymer-based formulations of next-generation RNA therapeutics and vaccines. Hear from research institutes and companies like the University of British Columbia, Kernal Biologics and Emory School of Medicine on the emerging strategies to enhance target specificity and protein expression of next-generation RNA therapeutics and vaccines

4

Tune into How Companies are Innovating Immunotherapy Approaches through Next Generation RNA Therapeutics
With advancing next-generation RNA therapeutics remaining a key challenge in the immunotherapy and oncology field, immerse yourself in the new approaches for immunotherapies in oncology and optimization of vectors, gene inserts and delivery with insights from Replicate Bioscience, Kernal Biologics and Strand Therapeutics

5

Combat Toxicology, Pharmacology & Scalability Challenges of Next-Generation RNA Therapeutics
Leveraging next-generation RNA therapeutics across different therapeutic areas requires advancing the toxicity, pharmacology and scalability considerations. Hear first-hand from Moderna, BioNTech and Orna Therapeutics on how to unravel the challenges of pharmacology, toxicology and regulator domains with therapeutic relevance

What Previous Attendees of our RNA Conference Series Have to Say:

"Engaged, connected, informed & excited for the advances in the field"

Previous Attendee, RNA Conference Series,
Eli Lilly

Lily

Previous Attendee, RNA Conference Series,
Eli Lilly

Previous Attendee, RNA Conference Series,
Pebble Labs

Pebble Labs Logo

"Extremely informative, high level of novelty & overall high scientific quality of presentations"

Previous Attendee, RNA Conference Series, 
Pebble Labs

"Excellent update on progress made with this very exciting new drug modality"

Previous Attendee, RNA Conference Series,
Ethris GmbH 

Ethris Logo

Previous Attendee, RNA Conference Series,
Ethris GmbH

Previous Attendee, RNA Conference Series, Independent Vaccine Consultant & Former Chief Medical Officer,
GSK Vaccines

GSK3

"Unique opportunity to be updated on cutting edge science"

Previous Attendee, RNA Conference Series, Independent Vaccine Consultant & Former Chief Medical Officer,
GSK Vaccines

"Excellent place to get exposed to the latest happenings in the RNA drug discovery field"

Previous Attendee, RNA Conference Series,
Arrakis Therapeutics

arrakis1

Previous Attendee, RNA Conference Series,
Arrakis Therapeutics

 

Previous Attendee, RNA Conference Series,  RNA Conference Series,
Depixus

 

Depixus Logo

"Very exciting conference! I was blown away by the expert line-up and left overwhelmed by the density of information packed in these 2 days"

Previous Attendee, RNA Conference Series,  RNA Conference Series,
Depixus